-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Black Diamond Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2018 to Q1 2025.
- Black Diamond Therapeutics, Inc. Depreciation for the quarter ending March 31, 2025 was $87K, a 1.16% increase year-over-year.
- Black Diamond Therapeutics, Inc. annual Depreciation for 2024 was $343K, a 21.5% decline from 2023.
- Black Diamond Therapeutics, Inc. annual Depreciation for 2023 was $437K, a 14% decline from 2022.
- Black Diamond Therapeutics, Inc. annual Depreciation for 2022 was $508K, a 148% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)